These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

118 related items for PubMed ID: 12358159

  • 1. A case of nonarteritic ischemic optic neuropathy (NAION) in a male patient taking sildenafil.
    Boshier A, Pambakian N, Shakir SA.
    Int J Clin Pharmacol Ther; 2002 Sep; 40(9):422-3. PubMed ID: 12358159
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Sildenafil citrate use and the incidence of nonarteritic anterior ischemic optic neuropathy.
    Gorkin L, Hvidsten K, Sobel RE, Siegel R.
    Int J Clin Pract; 2006 Apr; 60(4):500-3. PubMed ID: 16620369
    [Abstract] [Full Text] [Related]

  • 4. Sildenafil-associated nonarteritic anterior ischemic optic neuropathy.
    Pomeranz HD, Smith KH, Hart WM, Egan RA.
    Ophthalmology; 2002 Mar; 109(3):584-7. PubMed ID: 11874765
    [Abstract] [Full Text] [Related]

  • 5. Nonarteritic ischemic optic neuropathy developing soon after use of sildenafil (viagra): a report of seven new cases.
    Pomeranz HD, Bhavsar AR.
    J Neuroophthalmol; 2005 Mar; 25(1):9-13. PubMed ID: 15756125
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Case report: association of combined nonarteritic anterior ischemic optic neuropathy (NAION) and obstruction of cilioretinal artery with overdose of Viagra.
    Akash R, Hrishikesh D, Amith P, Sabah S.
    J Ocul Pharmacol Ther; 2005 Aug; 21(4):315-7. PubMed ID: 16117695
    [Abstract] [Full Text] [Related]

  • 8. Sildenafil-associated NAION.
    Gandhi JS.
    Ophthalmology; 2003 Sep; 110(9):1860-1; author reply 1861. PubMed ID: 13129901
    [No Abstract] [Full Text] [Related]

  • 9. Anterior ischemic optic neuropathy associated with viagra.
    Cunningham AV, Smith KH.
    J Neuroophthalmol; 2001 Mar; 21(1):22-5. PubMed ID: 11315976
    [Abstract] [Full Text] [Related]

  • 10. Non-arteritic anterior ischaemic optic neuropathy and the treatment of erectile dysfunction.
    McGwin G, Vaphiades MS, Hall TA, Owsley C.
    Br J Ophthalmol; 2006 Feb; 90(2):154-7. PubMed ID: 16424524
    [Abstract] [Full Text] [Related]

  • 11. Erectile Dysfunction Agents and Nonarteritic Anterior Ischemic Optic Neuropathy.
    Pomeranz HD.
    Neurol Clin; 2017 Feb; 35(1):17-27. PubMed ID: 27886893
    [Abstract] [Full Text] [Related]

  • 12. The Relationship Between Phosphodiesterase-5 Inhibitors and Nonarteritic Anterior Ischemic Optic Neuropathy.
    Pomeranz HD.
    J Neuroophthalmol; 2016 Jun; 36(2):193-6. PubMed ID: 26720519
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Non-arteritic anterior ischemic optic neuropathy associated with erectile dysfunction medications].
    Krashin-Bichler I, Dotan G.
    Harefuah; 2013 Feb; 152(2):84-7, 123. PubMed ID: 23513498
    [Abstract] [Full Text] [Related]

  • 15. Non-arteritic anterior ischemic optic neuropathy (NAION) and phosphodiesterase type-5 inhibitors.
    Bella AJ, Brant WO, Lue TF, Brock GB.
    Can J Urol; 2006 Oct; 13(5):3233-8. PubMed ID: 17076943
    [Abstract] [Full Text] [Related]

  • 16. NAION and treatment of erectile dysfunction: reply from Pfizer.
    Sobel RE, Cappelleri JC.
    Br J Ophthalmol; 2006 Jul; 90(7):927. PubMed ID: 16782965
    [No Abstract] [Full Text] [Related]

  • 17. Acute nonarteritic anterior ischemic optic neuropathy and exposure to phosphodiesterase type 5 inhibitors.
    Campbell UB, Walker AM, Gaffney M, Petronis KR, Creanga D, Quinn S, Klein BE, Laties AM, Lewis M, Sharlip ID, Kolitsopoulos F, Klee BJ, Mo J, Reynolds RF.
    J Sex Med; 2015 Jan; 12(1):139-51. PubMed ID: 25358826
    [Abstract] [Full Text] [Related]

  • 18. Anterior ischemic optic neuropathy and stroke with use of PDE-5 inhibitors for erectile dysfunction: cause or coincidence?
    Carter JE.
    J Neurol Sci; 2007 Nov 15; 262(1-2):89-97. PubMed ID: 17706972
    [Abstract] [Full Text] [Related]

  • 19. Are phosphodiesterase type 5 inhibitors associated with vision-threatening adverse events? A critical analysis and review of the literature.
    Azzouni F, Abu samra K.
    J Sex Med; 2011 Oct 15; 8(10):2894-903. PubMed ID: 21771280
    [Abstract] [Full Text] [Related]

  • 20. Prospective Case-crossover Study Investigating the Possible Association Between Nonarteritic Anterior Ischemic Optic Neuropathy and Phosphodiesterase Type 5 Inhibitor Exposure.
    Flahavan EM, Li H, Gupte-Singh K, Rizk RT, Ruff DD, Francis JL, Kinchen KS.
    Urology; 2017 Jul 15; 105():76-84. PubMed ID: 28336289
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.